← Companies|Pierre Fabre
Pi

Pierre Fabre

Castres FRFounded 196110,000 employees
Private CappharmaPrivateDermatologyOncology
Platform: Derm Onc
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ZoritinibPIE-1060Approved1mAbPLK4CGRPantPBCADHD
PIE-7717PIE-7717Preclinical1mRNAIL-13EZH2iRSV
PemimavacamtenPIE-7223Phase 12ADCPI3KαCAR-T CD19WMLGS
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)
2025-03-09
Pemimavacamten Interim
WM
Past
2026-05-03
PIE-7717 Orphan Drug
RSV
Orphan Drug
2028-06-11
PIE-7717 Interim
RSV
Interim
2029-03-09
Zoritinib Ph3 Readout
PBC
Ph3 Readout
2031-12-09
Pemimavacamten Interim
LGS
Interim